Tilray (NASDAQ:TLRY) Trading Up 1.4%

Tilray Inc (NASDAQ:TLRY)’s stock price was up 1.4% during mid-day trading on Monday . The stock traded as high as $1.77 and last traded at $1.77. Approximately 2,569,867 shares changed hands during mid-day trading, a decline of 90% from the average daily volume of 25,098,781 shares. The stock had previously closed at $1.74.

Tilray Stock Performance

The company has a market cap of $1.39 billion, a P/E ratio of -4.11 and a beta of 2.13. The company has a 50 day moving average price of $1.82 and a 200-day moving average price of $1.87. The company has a quick ratio of 1.42, a current ratio of 2.27 and a debt-to-equity ratio of 0.10.

Tilray (NASDAQ:TLRY) last released its quarterly earnings results on Monday, July 29th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.02). Tilray had a negative return on equity of 2.63% and a negative net margin of 30.26%. The business had revenue of $229.90 million during the quarter, compared to the consensus estimate of $226.20 million. During the same period in the previous year, the company posted ($0.15) EPS. The company’s revenue for the quarter was up 24.8% compared to the same quarter last year. Equities analysts expect that Tilray Inc will post -0.16 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of TLRY. Prospect Financial Services LLC acquired a new position in shares of Tilray in the 2nd quarter valued at $26,000. RPO LLC acquired a new position in shares of Tilray in the 4th quarter valued at $28,000. Simplicity Wealth LLC acquired a new position in shares of Tilray in the 1st quarter valued at $28,000. Wellington Wealth Strategies LLC. acquired a new position in shares of Tilray in the 4th quarter valued at $29,000. Finally, Signature Estate & Investment Advisors LLC acquired a new position in shares of Tilray in the 2nd quarter valued at $29,000. Institutional investors own 9.35% of the company’s stock.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.